412 POSTER A first-in-man phase I study of TH-302, a hypoxia-activated cytotoxic prodrug
G.J. Weiss, J.R. Infante, M. Borad, V.K. Langmuir, S. Kroll, D. Jung, R. Tibes, E.G. Chiorean, S.F. Jones, H.A. BurrisVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72346-2
File:
PDF, 79 KB
english, 2008